Cost-effectiveness analysis of Dapagliflozin versus Canagliflozin in treatment of type 2 diabetes mellitus
Sadagoban Gopal Krishnamoorthy, Jemi Rachel Shaji, Bhagya Premnath, Akshitha Rani Siby, Swathi Swaroopa Borra , Ayilya Manomohan, Arun Kanniyappan Parthasarathy
DOI: 10.7324/JAPS.2022.120318Pages: 171–178
